Clinical Investigations
Quantitative evaluation for lung glucose metabolism using 18F-FDG PET imaging in patients with pulmonary arterial hypertension related to congenital heart disease
Wang Xinhui, Wang Lei, Zhang Hailong, Guo Lin, Yan Chaowu, Li Li
Published 2021-10-25
Cite as Chin J Nucl Med Mol Imaging, 2021, 41(10): 613-616. DOI: 10.3760/cma.j.cn321828-20200612-00231
Abstract
ObjectiveTo investigate the value of 18F-fluorodeoxyglucose (FDG) PET imaging in evaluating the 18F-FDG influx rate of lungs and its relationship with parameters of pulmonary hemodynamics in patients with pulmonary arterial hypertension related to congenital heart disease (PAH-CHD).
MethodsFrom January 2018 to June 2019, a total of 16 PAH-CHD patients (6 males, 10 females, age (29.2±10.6) years) and 22 health controls who received physical examinations (8 males, 14 females, age (45.4±3.8) years) in Fuwai Hospital were respectively enrolled. All cases underwent dynamic 18F-FDG PET imaging for whole lung 18F-FDG influx rate (presented as Ki). Right heart catheterization was performed to evaluate pulmonary hemodynamic parameters such as pulmonary vascular resistance (PVR), mean pulmonary vascular pressure (mPAP) in PAH-CHD patients after imaging within one week. Independent-sample t test was used to compare Ki of 2 groups, and Pearson correlation analysis was used to analyze the relationship between Ki and PVR, mPAP in PAH-CHD patients.
ResultsKi of the lungs was significantly higher in PAH-CHD patients than that in controls ((0.000 6±0.000 3) vs (0.000 4±0.000 3) ml·g-1·min-1; t=2.15, P=0.038). Ki was not correlated with PVR ((10.86±4.45) Wood units) or mPAP ((69.75±18.93) mmHg; 1 mmHg=0.133 kPa) in PAH-CHD patients (r values: 0.202 and 0.006, both P>0.05).
ConclusionsPulmonary vascular remodeling can lead the increasing lung 18F-FDG uptake in patients with PAH-CHD. 18F-FDG PET may have the ability in monitoring and evaluating pulmonary vascular remodeling in PAH-CHD.
Key words:
Hypertension, pulmonary; Heart defects, congenital; Positron-emission tomography; Deoxyglucose
Contributor Information
Wang Xinhui
Department of Structural Heart Disease, Fuwai Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100037, China
Wang Lei
Department of Nuclear Medicine, Fuwai Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100037, China
Zhang Hailong
Department of Nuclear Medicine, Fuwai Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100037, China
Guo Lin
Department of Nuclear Medicine, Fuwai Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100037, China
Yan Chaowu
Department of Structural Heart Disease, Fuwai Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100037, China
Li Li
Department of Pathology, Fuwai Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100037, China